Child Vaccination Scheduling in China

NCT ID: NCT07141875

Last Updated: 2025-08-26

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

NOT_YET_RECRUITING

Total Enrollment

6000 participants

Study Classification

OBSERVATIONAL

Study Start Date

2025-08-25

Study Completion Date

2025-10-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

This study aims to optimize pediatric vaccine scheduling in China . The first objective is to gather information on current vaccine schedules in China. The second objective is to evaluate the impact of simultaneous vaccination and combination vaccines on costs and vaccination rates through feedback from caregivers and vaccination staff.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

The first objective will comprehensively collect vaccination programs for children under 6 years old in all 31 provinces of China (excluding Hong Kong, Macau, and Taiwan), covering both NIP and non-NIP vaccines that are suitable for children. The second objective is to evaluate the impact of simultaneous vaccination and combination vaccines on costs and vaccination rates. This will involve analyzing vaccination coverage for simultaneous vaccines across different regions in China, as well as assessing caregivers' perspectives on simultaneous vaccination, including their willingness, preferences, and factors influencing their vaccination decisions. Additionally, the study will explore vaccination staff attitudes, recommendation behaviors, and their reasons for recommending simultaneous and combination vaccines. For the survey, the sample will consist of caregivers of children (aged between 2 to 59 months) from 10 representative provinces/municipalities/autonomous regions as well as vaccination staff from institutions in the respective regions.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Vaccination Behavior

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

ECOLOGIC_OR_COMMUNITY

Study Time Perspective

CROSS_SECTIONAL

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

• Caregiver of Children

Interviewees are parents or grandparents of children aged between 6 to 59 months.

No intervention

Intervention Type OTHER

This is an observational study without any interventions.

Vaccination and health care personnel

Interviewees are vaccination and health care personnel in each study site.

No intervention

Intervention Type OTHER

This is an observational study without any interventions.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

No intervention

This is an observational study without any interventions.

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

\- For caregivers of children

* Children aged ≥2 months and ≤59 months
* Caregivers informed consent obtained For vaccination staff
* All vaccination staff currently working at the selected community health service centers or township health clinics on the day of the survey For retrospective analysis
* Children aged 5 years and under; with complete vaccination records. Complete vaccination records refer to a child having received all vaccines required by the NIP for their age group, with accurate dates recorded for each vaccination dose.

Exclusion Criteria

\- For caregivers of children

* Caregivers who are unable to participate in the survey due to physical or other objective reasons
* Caregivers with communication barriers
* Caregivers who do not consent to participate in the survey For vaccination staff
* Vaccination staff who do not consent to participate in the survey For retrospective analysis
* Children whose vaccination records are missing or incomplete
* Children whose vaccination has been delayed or not received due to medical contraindications.
Minimum Eligible Age

2 Months

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Centers for Disease Control and Prevention, China

OTHER_GOV

Sponsor Role collaborator

MSD China Holding Co Ltd

UNKNOWN

Sponsor Role collaborator

Peking University

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Peking University Health Science Center

Beijing, Beijing Municipality, China

Site Status

Countries

Review the countries where the study has at least one active or historical site.

China

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

IRB00001052-25094

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.